0001555280-20-000142.txt : 20200306
0001555280-20-000142.hdr.sgml : 20200306
20200306171958
ACCESSION NUMBER: 0001555280-20-000142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200305
FILED AS OF DATE: 20200306
DATE AS OF CHANGE: 20200306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: David Glenn
CENTRAL INDEX KEY: 0001606256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35797
FILM NUMBER: 20695833
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC., 100 CAMPUS DRIVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zoetis Inc.
CENTRAL INDEX KEY: 0001555280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460696167
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-822-7000
MAIL ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
wf-form4_158353318091537.xml
FORM 4
X0306
4
2020-03-05
0
0001555280
Zoetis Inc.
ZTS
0001606256
David Glenn
C/O ZOETIS INC.
10 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
Chief Financial Officer
Common Stock
2020-03-05
4
M
0
11144
50.22
A
36885
D
Common Stock
2020-03-05
4
M
0
32634
55.02
A
69519
D
Common Stock
2020-03-05
4
S
0
35838
140.81
D
33681
D
Common Stock
2020-03-05
4
S
0
7940
141.24
D
25741
D
Stock Option
2020-03-05
4
M
0
11144
0
D
Common Stock
11144.0
110103
D
Stock Option
2020-03-05
4
M
0
32634
0
D
Common Stock
32634.0
77469
D
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.11 to $141.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.12 to $141.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
11,144 options granted December 6, 2016 at an exercise price of $50.22 per option.
Each option vests on the third anniversary of the date of grant.
Each option expires on the tenth anniversary of the date of grant.
7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; and 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option.
32,634 options granted February 14, 2017 at an exercise price of $55.02 per option.
7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; and 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option.
/s/ Katherine H. Walden, as Attorney-in-Fact
2020-03-06